The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series

Abstract Objectives To describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center. Methods We performed a retrospective review of patients with MOG antibodies. Results We review the clinical presentation of 11 patients with MOG antibodies. In patients seen at Duke University Health System with MOG antibodies, the most common presentation was optic neuritis. Rituximab was the most used treatment for long-term management. Conclusions Our case series highlights the common presentation of MOG antibody disease (MOG-AD) at a single academic medical center.